Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Total value of everything the company owns
3Y CAGR
-1.5%/yr
vs +44.7%/yr prior
5Y CAGR
+45.8%/yr
Recent deceleration
Acceleration
-46.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
6.6x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $76.90M | -5.6% |
| 2023 | $81.44M | -28.7% |
| 2022 | $114.19M | +42.1% |
| 2021 | $80.39M | +21.1% |
| 2020 | $66.40M | +468.9% |
| 2019 | $11.67M | -21.6% |
| 2018 | $14.89M | -18.8% |
| 2017 | $18.34M | -18.6% |
| 2016 | $22.53M | -15.3% |
| 2015 | $26.59M | - |